Product Program year 2025 Source: CMS Open Payments

SpyGlass

Device Spyglass DS_ENDO

PDI 08714729764441

Open in the dashboard

General payments

$320,771

1,108 payments

Research payments

$0

0 payments

Through program year 2025, $320,771 in general payments and $0 in research payments were reported against SpyGlass (Spyglass DS_ENDO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $94,288 396
2024 General $78,568 367
2023 General $112,742 301
2022 General $35,173 44

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $320,771 1,108 payments
Top recipients General payments · program year 2025
  1. Harshit Khara Gastroenterology · Danville, PA $17,806 19% · 13 payments
  2. Isaac Raijman Gastroenterology · Houston, TX $15,590 17% · 13 payments
  3. Veeral Oza Gastroenterology · Greenville, SC $9,819 10% · 13 payments
  4. Sumit Singla Gastroenterology · Detroit, MI $5,775 6% · 10 payments
  5. Ara Sahakian Gastroenterology · Los Angeles, CA $4,419 5% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $89,562 96% · 164 practitioners
  2. Internal Medicine $707 <1% · 8 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $378 <1% · 8 practitioners
  4. Surgery $346 <1% · 6 practitioners
  5. Pediatric Gastroenterology Pediatrics $215 <1% · 3 practitioners

The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $19,583 21% · 35 recipients
  2. Pennsylvania $18,725 20% · 5 recipients
  3. South Carolina $9,929 11% · 5 recipients
  4. California $8,830 9% · 12 recipients
  5. Florida $6,221 7% · 28 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,108 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record